These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7766722)

  • 1. Determination of MK-0476 in human plasma by liquid chromatography.
    Amin RD; Cheng H; Rogers JD
    J Pharm Biomed Anal; 1995 Feb; 13(2):155-8. PubMed ID: 7766722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching.
    Liu L; Cheng H; Zhao JJ; Rogers JD
    J Pharm Biomed Anal; 1997 Feb; 15(5):631-8. PubMed ID: 9127275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detection.
    Ochiai H; Uchiyama N; Takano T; Hara K; Kamei T
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):409-14. PubMed ID: 9746257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
    Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
    J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection.
    Kitchen CJ; Wang AQ; Musson DG; Yang AY; Fisher AL
    J Pharm Biomed Anal; 2003 Mar; 31(4):647-54. PubMed ID: 12644191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.
    Schoors DF; De Smet M; Reiss T; Margolskee D; Cheng H; Larson P; Amin R; Somers G
    Br J Clin Pharmacol; 1995 Sep; 40(3):277-80. PubMed ID: 8527292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of montelukast, a selective cysteinyl leukotriene receptor (CysLT1) antagonist in human plasma by liquid chromatography-mass spectrometry: validation and its application to a human pharmacokinetic study.
    Bharathi DV; Hotha KK; Jagadeesh B; Mullangi R; Naidu A
    Biomed Chromatogr; 2009 Aug; 23(8):804-10. PubMed ID: 19309765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple bioanalytical assay for determination of montelukast in human plasma: application to a pharmacokinetic study.
    Sripalakit P; Kongthong B; Saraphanchotiwitthaya A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):38-44. PubMed ID: 18508416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma.
    Al-Rawithi S; Al-Gazlan S; Al-Ahmadi W; Alshowaier IA; Yusuf A; Raines DA
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):527-31. PubMed ID: 11339297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective determination of R(-)- and S(+)-MK-571, a leukotriene D4 antagonist, in human plasma by chiral high-performance liquid chromatography.
    Robinett RS; Hsieh JY
    J Chromatogr; 1991 Sep; 570(1):157-65. PubMed ID: 1797821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An automated sample preparation and high performance liquid chromatographic method for the determination of MK-591, a novel leukotriene biosynthesis inhibitor, in human plasma.
    Lin C; Hsieh JY; Matuszewski BK; Dobrinska MR
    J Pharm Biomed Anal; 1996 Aug; 14(11):1601-8. PubMed ID: 8877868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid.
    Zamboni R; Belley M; Champion E; Charette L; DeHaven R; Frenette R; Gauthier JY; Jones TR; Leger S; Masson P
    J Med Chem; 1992 Oct; 35(21):3832-44. PubMed ID: 1331447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antinociceptive effect of leukotriene D(4) receptor antagonist, MK-571, in mice: possible involvement of opioidergic mechanism.
    Gök S; Onal A; Cinar MG; Evinç A
    Eur J Pharmacol; 1999 Dec; 386(2-3):195-200. PubMed ID: 10618470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic method for the determination of a novel leukotriene D4 antagonist (MK-0571) in biological specimens.
    Berna RA; Zacchei AG
    J Chromatogr; 1991 Feb; 563(2):458-65. PubMed ID: 2056010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereospecific HPLC method for the quantitation of the enantiomers of MK-0571, a potent leukotriene D4 receptor antagonist, in biological specimens.
    Lee LL; Zacchei AG
    Chirality; 1991; 3(2):129-35. PubMed ID: 1650571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bioavailability and nonlinear pharmacokinetics of MK-679 in humans.
    Cheng H; Schwartz JI; Lin C; Amin RD; Seibold JR; Lasseter KC; Ebel DL; Tocco DJ; Rogers JD
    Biopharm Drug Dispos; 1994 Jul; 15(5):409-18. PubMed ID: 7981429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive and rapid liquid chromatography/tandem mass spectrometric assay for the quantification of piperaquine in human plasma.
    Singhal P; Gaur A; Gautam A; Varshney B; Paliwal J; Batra V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):24-9. PubMed ID: 17923446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Frenette R; Gauthier JY; Leger S; Masson P
    Can J Physiol Pharmacol; 1989 Jan; 67(1):17-28. PubMed ID: 2540892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.